Health● Low1h ago · Nov 11, 2026, 2:42 AM
Capricor outlines 2027 manufacturing validation as Deramiocel BLA heads toward Nov. 22 PDUFA date
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Capricor has detailed its manufacturing validation plans for 2027 as its Deramiocel BLA approaches a PDUFA date of November 22. This update is important for the company's product development and regulatory timeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Health
Not flagged as developing.
More in Health
Health1h agoGLP-1 drugs to carry warning about rare vision-loss side effect, FDA saysCBS NewsHealth2h agoMarine veteran to receive new smile through Smiles for Soldiers kcbd.com · United StatesHealth3h agoMeasles cases explode amid declining vaccination ratesNBC NewsHealth3h ago“I wanted life to be prioritized” Lessons from Minamata: Crisis repeated in the AmazonAsahi Shimbun